CUREDUCHENNEBLOG.ORG

CONTENT

PAGE TITLE

CureDuchenne Founder’s Blog | cureduchenneblog.org Reviews

<META>
DESCRIPTION

CureDuchenne Founder’s Blog. The Thoughts and Findings of CureDuchenne Founder Debra Miller. Europe Approves High-Price Gene Therapy. Ndash; November 2nd, 2012. LONDON (Reuters) – European officials have approved the Western world’s first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty genes. Patients with LPLD, which affects no more than one or two people per million, are unable to handle fat particles in their blood and are at risk...

<META>
KEYWORDS

1 by ben hirschler

2 earlier setbacks

3 0 comments

4 posted in uncategorized

5 ends

6 notes to editors

7 about dmd

8 about exon skipping

9 about prosensa

10 prosensa enquiries

CONTENT

Page content here

KEYWORDS ON
PAGE

by ben hirschler,earlier setbacks,0 comments,posted in uncategorized,ends,notes to editors,about dmd,about exon skipping,about prosensa,prosensa enquiries,media enquiries,prosensa@collegehill com,baseline in %,dystrophin,positive fibers,placebo/delayed

SERVER

nginx/1.12.2

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

CureDuchenne Founder’s Blog | cureduchenneblog.org Reviews

https://cureduchenneblog.org

CureDuchenne Founder’s Blog. The Thoughts and Findings of CureDuchenne Founder Debra Miller. Europe Approves High-Price Gene Therapy. Ndash; November 2nd, 2012. LONDON (Reuters) – European officials have approved the Western world’s first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty genes. Patients with LPLD, which affects no more than one or two people per million, are unable to handle fat particles in their blood and are at risk...